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Abstract 
Density functional theory and ab-initio methods have been employed to address the 
impacts of hydroxyl (OH) group substitutions on the physico-chemical properties of 
levodopa (or L-dopa) against the natural amino acids, phenylalanine and tyrosine.  L-
dopa, which is an important therapeutic drug for Parkinson’s disease, shares structural 
homology with the amino acids, whose structures differ only by OH substitutions in 
their phenyl side chains. It is revealed that the backbone geometries of the aromatic 
molecules do not show apparent OH-dependent differences; however, their other 
molecular-level properties, such as molecular dipole moment, electronic properties 
and aromaticity, change significantly. The core binding energy spectra indicate that 
the atom sites that undergo modifications exhibit large energy shifts, so as to 
accommodate the changes in the intra-molecular chemical environment of the 
molecules. The binding energies of the modified C 1s sites in the molecules shift as 
much as 1.8 eV, whereas the electronic changes in their O 1s spectra happen in the 
higher energy region (ca. 536 eV). The valence spectra provide enhanced insights on 
the reactivity and chemical properties of the aromatic molecules. The impacts of OH 
moieties on the valence spectra are predominantly focussed in the energy band < 16 
eV, where the frontier molecular orbitals display much reorganization and energy 
shifts from the amino acids to L-dopa. Of the three molecules, L-dopa also has the 
least HOMO-LUMO energy gap, which can readily explain its proactivity as a drug 
compound. Furthermore, the nuclear independent chemical shift calculations suggest 
that L-dopa also has more aromaticity features than those of the amino acids. The OH 
groups, therefore, play a more prominent role in shaping the physico-chemical 
properties of L-dopa, which significantly improve its drug potency.  
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Introduction 
Many compounds based on phenols exhibit strong antioxidant properties in biological 
systems. Understanding their structures, properties and interactions will help us to 
reveal information in a number of biochemical and physiological processes1-4. For 
example, the conversion of tyrosine (an amino acid) into dopamine (a 
neurotransmitter) is one of such significant biochemical transformations of aromatic 
amino acids5-8. Such the transformation is found to be initiated by an enzyme known 
as phenylalanine hydroxylase, which converts L-phenylalanine (L-phe) into L-
tyrosine (L-tyr)9, 10. L-tyr can be converted into dopamine, which controls the signal 
transactions between nerve cells in the brain11. However, L-tyr is not directly 
biosynthesised into dopamine, but via an intermediate product known as levodopa or 
L-dopa or 3,4-dihydroxyl-L-phenylalanine5, 6. A non-heme iron enzyme, tyrosine 
hydroxylase, uses molecular oxygen to attach an additional hydroxyl group to the 
phenol moiety of tyrosine, thereby synthesising L-dopa with a catechol side chain12. 
Later, a dopa decarboxylase enzyme catalyses the decarboxylation of L-dopa, thereby 
synthesizing dopamine as the end product. Fig. 1 presents the sequential biochemical 
transformation of L-phe to dopamine.  
The three molecules, that is, L-dopa and its amino acid precursors, L-phe and 
L-tyr, share a common phenyl structure with variations with respect to the OH group 
on the aromatic ring. Conceptually, L-tyr can be represented as ‘L-phe + para-OH’ 
and L-dopa can be described as ‘L-tyr + meta-OH’ (as shown in Fig. 1). However 
their physico-chemical properties are significantly different. For instance, while L-phe 
and L-tyr are amino acids that serve as natural protein building blocks, L-dopa is a 
popular catecholamine neurotransmitter drug that is widely used for the treatment of 
Parkinson’s and other neurodegenerative disorders6, 13-15. L-dopa exhibits a unique 
drug potency to cross the blood-brain barrier. As soon as L-dopa crosses the blood-
brain barrier and enters the central nervous system, it is converted into dopamine by 
the dopa decarboxylase enzyme (Fig. 1). In addition, L-dopa is also useful in dual-
targeting the monoamine oxidase enzyme16 and the adenosine receptors at the same 
time15. As a result, L-dopa remains an attractive drug in the fight against Parkinson’s 
disease. A variety of L-dopa formulations are also available in the clinical market for 
the treatment‡.  
                                                
‡ http://www.epda.eu.com/en/parkinsons/medinfo/levodopa/  
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L-phe and L-tyr are known to exist in a great number of low energy stable 
conformations, as shown by a number of experimental17-31 and theoretical studies32-38. 
For example, Prince and co-workers recently studied the different conformers of 
aromatic amino acids and their effects on the electronic structures of the molecules 
using synchrotron sourced soft XPS techniques17, 26. However, it was recently shown 
by a combined laser desorption supersonic jet laser spectroscopy and quantum 
chemical studies5, 39 that L-dopa is dominated by only a single stable conformation in 
the gas phase5, 39. The reason behind such a dramatic conformational reduction in L-
dopa is not clear and the intra-molecular H-bonds are suspected as a dominating 
factor39.  
What is the role that the OH groups play in L-dopa, which significantly 
improve its drug potency? Structure-related changes in L-dopa unravel the innate 
physico-chemical properties of the molecule, which can be useful for understanding 
biological phenomena40, 41. Therefore, comparatively studying the structural and 
electronic properties of those aromatic molecules, i.e., L-phe and L-tyr against L-
dopa, reveal information, which helps to understand the structure-property 
relationships of L-dopa.  
The electronic properties of L-phe and L-tyr have been reported by different 
methods such as, photoemission spectroscopy (PES)26-29, 42, near edge x-ray 
absorption fine structure (NEXAFS) spectroscopy43, 44, electron energy loss 
spectroscopy (EELS)45, etc.  For example, Zhang et al17 studied the electronic 
structures of the aromatic amino acids in the gas phase using the X-ray photoemission 
spectroscopy (XPS) and NEXAFS technique. The study17 reported that the N 1s core 
level spectra of L-phe and L-tyr in gas phase can indicate conformer population, 
while their N K-edge spectra do not show conformational effects. The valence PES 
spectra of the aromatic amino acids have also been reported previously26-29, 42, 46. 
However, the energy and the assignment of the highest occupied molecular orbital 
(HOMO) of the amino acids, particularly L-phe, have often been debated by previous 
studies26-29, 47, 48.  
Retrieving complete information from the measured valence spectra, on the 
other hand, is sometimes difficult, as the measured spectral peaks are mostly broad 
and congested due to overlapping ionization bands. As a result, theoretical 
calculations can be useful to study the entire valence region of bio-molecules by 
relating the spectral features with their electronic structures36, 38, 49-54. For instance, 
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our previous theoretical studies36, 37 on the intra-molecular interactions in L-phe in the 
gas phase revealed that the inner shell of the amino acid is dominated by the 
functional group substitutions, while the fragment interactions are vital in its’ valence 
electronic space. Nevertheless, there have been limited studies on the electronic 
structures of L-dopa, except for a recent study of L-dopa in solid phase55.  
In the present study, we analyse the effects of the hydroxyl groups on the 
structural, electronic and aromaticity properties of the model molecules, from L-phe 
and L-tyr amino acids to L-dopa, using ab-initio and density functional theory (DFT) 
methods. The aim of this work is to understand the profound changes in the properties 
of the molecules caused by addition of the OH groups.  
 
Computational details 
In the present study, the structures of the molecules are based on the conformations of 
L-phe35, L-tyr34, and L-dopa5 reported in the literature. The conformers are re-
optimised using the B3LYP/6-311G** model, which has provided accurate 
geometries for L-phe and other amino acids in our previous studies37, 52, 53, 56. The 
optimized structures and their nomenclatures are given in Fig. 2. 
Single point calculations at the optimized structures are carried out using 
different quantum chemical models, such as LB94/et-pVQZ57 for core shell and 
SAOP/et-pVQZ58, 59 and OVGF/TZVP60 for valence space.  Here, the et-pVQZ basis 
set denotes the even-tempered polarized valence quadruple-zeta Slater-type basis set 
and the OVGF/TZVP is the outer valence Greens function combined with the triple 
zeta valence polarized basis set. The DFT based SAOP model and the Green’s 
function based OVGF model have been efficient in calculating the accurate valence 
IPs for amino acids36, 52, 56 and other bio-molecules49, 54, 61, 62. The former model is 
able to calculate the IPs in the entire valence space, while the latter is applicable for 
calculations of the outer valence IPs with required accuracy. Moreover, it is 
ascertained that the SAOP model slightly over-estimates the outermost valence IPs, 
especially the IP of the HOMOs, whereas the OVGF produces more accurate IPs in 
this region51, 53, 56, 61. Hence combining both the SAOP and OVGF models can, 
therefore, achieve good correlation between the calculated valence IPs and the 
experiments. 
Aromaticity plays an important role in the chemical reactions and stabilities63
 6 
65 of aromatic molecules. As a result, the nucleus independent chemical shift (NICS) 
index66-68 is employed to study the aromaticity properties of the molecules. In this 
approach, a dummy atom is usually placed at the ring center (the approach is known 
as ‘NICS(0)’) or 1 Å above the ring (i.e., NICS(1)) and the magnetic shielding is 
calculated. The negative magnetic shielding is the NICS value. Noorizadeh and 
Dardab69 have introduced the NICS-rate index that is based on the disparity of NICS 
indices at varying distances from the ring. This NICS-rate index is used in this study 
to evaluate the aromaticity features of L-phe, L-tyr and L-dopa. 
 
All the calculations based on B3LYP/6-311G** and OVGF/TZVP models are 
carried out using the Gaussin0970 computational chemistry program, whereas the 
LB94/et-pVQZ and SAOP/et-pVQZ calculations are accomplished using the 
Amsterdam density functional (ADF)71 package.  
 
Results and discussion 
A. Molecular properties 
The selected molecular properties of L-phe, L-tyr and L-dopa calculated by the 
B3LYP/6-311G** model are given in Table 1, while their complete geometric 
parameters together with available measurements31, 72 are provided in the 
supplementary information SI.1). As seen in SI.1 and Table 1, no apparent changes 
are observed in the geometric parameters across the three molecules, including their 
bond lengths and bond angles. For example, the ring perimeters, R6, are almost the 
same: 8.37 Å for L-phe, 8.38 Å for both L-tyr and L-dopa. Even the dihedral angles 
do not change significantly. For example, the largest change in ∠C(1)-C(α)-C(β)-C(γ), is 
approximately 1° from L-phe (-73.89°) to L-dopa (-72.36°).  
Although the molecules do not exhibit significant geometric changes, their 
electronic charges have been apparently redistributed, leading to clear variations in 
their dipole moments. The dipole moment of L-phe is 4.88 Debye, but 3.73 Debye for 
L-tyr and even smaller (2.86 Debye) for L-dopa. The para-OH in L-tyr, and para-OH 
and meta-OH groups in L-dopa balance the charge distributions through the aromatic 
phenyl ring, as also indicated by the Hirshfeld charges, which are given in Fig. 2.  
The Hirshfeld charges (QH) in Fig. 2 indicate very different charge distribution 
of the molecules. The molecules can be separated by the C(α)-C(β)-C(γ) bridge, which 
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connects the methyl carbon (C(β)) of the amino acid moiety and the aromatic phenyl 
moieties of the molecules. The aromatic phenyl moieties of L-tyr and L-dopa serve as 
a buffer to accommodate the changes caused by the hydroxyl groups in L-tyr and L-
dopa. For example, in L-phe, apart from the QH on C(γ), which is one of the six 
carbons in the phenyl ring and connecting directly with C(β), the charges on the other 
carbon atoms in the phenyl ring are more or less balanced between -0.040e and -
0.051e. The QH of C(γ) in L-phe is given by +0.008e. In L-tyr, which has one –OH 
group at the para-position of the phenyl, all of the carbon atoms in the phenyl ring are 
affected; but the most significant changes in QH concentrate on the C(γ) and the para 
carbon, C(4), in Fig. 2. The QH of the former (C(γ)) changes from positive (+0.008e) to 
negative (-0.001e), whereas the QH of the latter (C(4)) changes significantly from -
0.045e (L-phe) to +0.078e (L-tyr) in order to balance the negative charge of O(3) in the 
–OH group. When the second –OH group is added on to the C(3) (meta) position of the 
phenyl ring to form L-dopa, the QHs of  the “orth” carbon atoms, C(2) (from -0.040e to 
-0.061e) and C(6) (from -0.048e to -0.057e) positions change considerably, with 
respect to C(4) changes. Nevertheless, the QH on one of the “meta” positions (i.e., C(5) 
site) remains little affected (from -0.056e to -0.055e). 
 
B. Inner shell changes 
Inner shell chemical shifts are very sensitive to local chemical environments of 
molecules and could serve as effective indicators that reflect the impact of OH 
substitution on the phenyl ring and intra-molecular hydrogen bonds in the model 
molecules73. Refer to Supplementary Information, SI.2 for all the intra-molecular 
hydrogen bond distances of the model molecules. Table 2 compares the inner shell 
vertical IPs of the aromatic molecules, L-phe, L-tyr and L-dopa, calculated using the 
LB94/et-pVQZ model against their respective available experimental IPs17. The LB94 
model accurately calculates the C 1s IPs for both L-phe and L-tyr, where their ΔIP% 
values are smaller than 1%.  It is a known fact that the core IP of the carbonyl C(=O) 
atom is underestimated, as it includes more electron correlations. For example, the 
C(=O) 1s energies of 2-azetodine were also overestimated by the LB94 and ΔE-KS 
methods when compared to the experimental measurements51. However the IP errors 
in the molecules become larger for the N 1s and O 1s IPs, but are still under 1%. For 
example, it is 0.49% for N 1s and 0.74% for O 1s, as shown in Table 2. In addition, 
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the IP energy differences can be compensated again by applying global energy shifts 
to our simulations, as shown in our previous studies37, 41, 49, 51.  
Fig. 3 compares the calculated C 1s (a) and O 1s (b) spectra of L-tyr in this 
work against a previously reported XPS measurement17. The C 1s spectrum simulated 
with a FWHM of 0.47 eV is globally shifted to the higher energy side by 0.45 eV to 
match the observed peak at ca. 290.00 eV. The theoretical spectrum reproduces 
excellently the ratio of peaks, their intensities and widths in the measured spectrum. 
For instance, the theoretical C 1s spectrum (Fig. 3(a)) of L-tyr produces three peaks 
that are consistently decreasing in their intensities, when the energy increases, in 
agreement with the measured C 1s spectrum. Indeed the energy gap between the most 
intense C 1s peak and the middle peak is in remarkable agreement with the measured 
spectra, while the energy gap between the middle peak and C(1) 1s peak shows some 
discrepancies. The theory, however, underestimates the C(1) 1s IP by ca. 1.76 eV. The 
two peaks in the O 1s spectrum simulated with a FWHM of 0.97 eV (Fig. 3(b)) agree 
well with the measurement, after a global shift of 3.52 eV.  
The calculated C 1s and O 1s spectra of L-phe, L-try and L-dopa are compared 
in Fig. 4(a) and Fig. 4(b), respectively. Please refer to Table 2 for their corresponding 
IPs. Each of the C 1s spectrum (FWHM of 0.40 eV) and O 1s (FWHM of 0.50 eV) 
spectrum displays a similar pattern in the three molecules, with the former showing 
three major peaks and the latter with two spectral peaks. The similarities in C 1s and 
O 1s spectra indicate that the molecules are related. The C 1s spectral peaks in Fig. 
4(a) are labelled as A, B and C. IPs of these peaks decrease from A to C, but their 
intensities show an increasing trend (from A to C). The O 1s spectra in Fig 4. (b), on 
the other hand, are the opposite: both IPs and spectral intensities of the two major 
peaks (labelled as D and E) decrease from D to E. 
In the C 1s spectra (Fig 4. (a)), the peak ‘A’ in the higher energy region (ca. 293 
eV) is dominated by the contribution from the carbonyl carbon atom, C(1)(=O), in the 
model molecules, which is very similar to other aliphatic amino acids56, 74, 75 and 
aromatic molecules17, 37, 38. Perhaps the most noticeable changes in the C 1s spectra of 
the molecules, due to the OH substitutions on the phenyl ring, are seen in the peak ‘B’ 
of the spectra, which is in a ratio of 1:2:3 for L-phe:L-tyr:L-dopa. This peak B in L-
phe is assigned to the C(α) atom37, 38. The carbon atoms, C(4) in L-tyr and C(4) and C(3) 
in L-dopa, which directly connect to the OH groups in the phenyl ring experience 
significant IP increase. For instance, the C(4) atom in L-tyr is attached to the O(3)-H 
 9 
group that in turn increases its IP by 1.75 eV, with respect to the IP of  C(4) in L-phe, 
thereby shifting the IP position of C(4) into the peak ‘B’ with C(α) in L-tyr. Similarly, 
the C(3) and C(4) atoms in L-dopa are attached to the O(4)-H and O(3)-H groups, 
respectively, and hence their IPs move into the ‘B’ peak, along with the C(α) atom, in 
L-dopa. As a result, the intensities of peak ‘B’ in L-tyr and L-dopa are twice or three 
times more than that of peak ‘B’ in L-phe.  Such changes in the peak B of the C 1s 
spectra are clearly reflected in the peak ‘C’ as well.  
The most intense peak ‘C’ in the lower energy side (ca. 289.5 eV) of the C 1s 
spectrum of L-phe denotes the strong asymmetric phenyl characters upon reduction of 
the high symmetry of benzene (D6h)36. A small extended shoulder in the ‘C’ peak (ca. 
290 eV) is due to the bridging atoms, C(β) and C(γ), that connect the amino acid moiety 
with the phenyl ring. However, re-ordering of the IPs of C(4) in L-tyr and C(4) and C(3) 
in L-dopa reduce the intensities of their ‘C’ peaks. Therefore, the growth of the 
middle peak ‘B’ and shrink of the peak ‘C’ in the C 1s spectra of the aromatic 
molecules reflect the direct impacts of OH group substitutions in the phenyl ring. The 
intensity ratio of peaks, A:B:C, is given by 1:1:7 in L-phe, 1:2:6 in L-tyr and 1:3:5 in 
L-dopa. 
The O 1s spectra of the model molecules given in Fig. 4(b), on the other hand, 
present two peaks (labelled as D and E) that are clearly separated by energy gaps. The 
peak ‘E’ in the lower energy side (ca. IP=534.5 eV) of the spectra is dominated by the 
O(1)(=C) atom in the molecules. This O 1s peak (i.e., peak ‘E’), which corresponds to 
the single C(1) 1s peak (i.e., peak ‘A’ in Fig. 4(a)), is in common for the molecule 
series in this study. This indicates that the C=O bonding is so strong that the IPs of the 
carbonyl C and O atoms are distinct from the other C and O atoms, which possess 
single bonds in the molecules. However, it is the peak ‘D’ at ca. 536 eV in the O 1s 
spectra, which differentiates the three molecules and serves as their signatures. For 
example, in L-phe, this peak ‘D’, which is assigned to the O(2) atom in its hydroxyl 
group, exhibits the same intensity envelop with peak ‘E’. But in L-tyr, this peak ‘D’ 
also receives contribution from the O(3) atom in the OH group in the phenyl ring. 
Hence the intensity of this peak ‘D’ of L-tyr is twice as large as peak ‘D’ in L-phe. 
Both oxygen atoms in the OH groups of L-tyr are very close in their IP energies, 
although one OH group is on the amino acid moiety and the other is in the phenyl 
ring. Such an accident “degeneracy” in IPs of the O 1s sites can be caused by their 
 10 
hydrogen bond networks in the vicinity of the O atoms in L-tyr (see Table SI.2). 
The higher IP peak ‘D’ in the O 1s spectrum of L-dopa is a broad and intense 
peak, which differentiates L-dopa from the amino acids, such as L-phe and L-tyr. The 
peak ‘D’ of L-dopa includes contributions from the three hydroxyl oxygen atoms such 
as O(2), O(3) and O(4). The OH groups in L-dopa are in very different chemical 
environments so that the peak ‘D’ splits. The calculated energy splitting (ΔIP) is 
given by 0.17 eV (between O(4) and O(2)) and 0.26 eV (between O(2) and O(3)). This O 
1s peak ‘D’ may split into two or even three peaks with sufficient experimental 
resolution. This indicates that addition of an hydroxyl group at C(3) (meta) of the 
phenyl ring makes significant impact on the electronic structure of L-dopa. It also 
breaks the accidental IP degeneracy in the O 1s spectrum of L-tyr. As a result, L-dopa 
will behave very differently from L-phe and L-tyr, supporting the fact that L-dopa is 
not an amino acid.  
Inner shell chemical shifts indicate that the C 1s and the O 1s spectra, and 
therefore the structures of the molecules, are significantly affected by the OH group 
substitutions. Indeed the effects are more prominent on the electronic structures and 
molecular properties than their geometries. Nevertheless, the N 1s IP of L-phe, L-tyr 
and L-dopa remains unaffected with an energy value of 403.7 eV. The local chemical 
environment of nitrogen atom in the three aromatic molecules, L-phe, L-tyr and L-
dopa, does not change. The aromatic phenyl ring serves as a buffer to accommodate 
the structural modifications. 
 
C. Effects in valence space 
Valence space information directly links to a number of chemical properties and 
reactivity of the molecules. Investigation of the valence spectra of L-phe, L-tyr and L-
dopa is important to unveil the effects of the OH substitutions with respect to their 
chemical properties. Fig. 5 compares the recently measured high resolution valence 
XPS26 (middle panel) of L-tyr with the theoretical spectra simulated using the 
SAOP/et-pVQZ (bottom panel) and the OVGF/6-311G** (top panel) models in this 
study. The spectroscopic pole strengths of the outer valence IPs calculated by OVGF 
model are ≥ 0.85 eV, demonstrating that the single particle approximation used in this 
model holds appropriate in the study. The theoretical spectra obtained with a FWHM 
of 0.50 eV are globally shifted by 1.40 eV and 0.38 eV in SAOP and OVGF, 
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respectively; thereby aligning the HOMO peaks in the experimental and theoretical 
spectra at 8.47 eV. The calculated spectrum exhibits excellent agreement with the 
measured spectral features, such as their shapes and intensities. In fact both OVGF 
and SAOP models reproduce the outer valence measurements accurately, while the 
latter model (SAOP) continues to produce the inner valence region (i.e., > 20 eV), as 
shown in Fig. 5. 
Fig. 6 compares the simulated valence XPS of the aromatic molecules, obtained 
using the SAOP/et-pVQZ model with a FWHM of 0.40 eV. The corresponding 
valence vertical IPs are given in supplementary information (SI.3). Although the 
valence spectra are more complex than the core spectra discussed before, the valence 
spectra of the molecules clearly display similarities and differences which can be 
understood from their structures. The valence spectra of the molecules again suggest 
that the molecules are related. Four regions of the valence spectra will be discussed in 
this section: innermost valence region of IP>26 eV, inner valence region of 26 eV > 
IPs > 18, the valence region of 18 eV < IP < 12 eV and the outer valence region of IP 
< 12 eV.  
Three orbitals in the innermost valence region (IP>26 eV) of L-phe are 
dominated by the 2s electron contributions of the oxygen atoms in the carboxyl group 
and orbital 15a is dominated by the amino group36, 38. The IP energy gaps between 
13a and 14a (from oxygen atoms in the carboxyl) and 14a and 15a are 2.06 eV and 
2.67 eV, respectively (see SI.3 and also Fig. 6). The innermost valence orbital of L-tyr 
(14a) and L-dopa (15a) are also dominated by the carboxyl group, as shown in Fig.  6, 
while the IP peaks of orbital 17a (in L-tyr) and orbital 19a (in L-dopa) are dominated 
by the amino contributions. Although more new peaks appear in this valence region 
(particularly between 30-32 eV) in L-tyr and in L-dopa, due to additional OH groups, 
they do not noticeably change the original three peaks which are related to 13a, 14a 
and 15a of L-phe. The additional new peaks, at 32.26 eV in L-tyr and at 30.86 eV and 
31.58 eV in L-dopa, are highlighted and their orbital diagrams, which belong to the 
oxygen atom(s) of the hydroxyl groups on the phenyl ring of L-tyr and L-dopa, are 
also given in Fig. 6. The innermost valence MOs (molecular orbitals), which are 
dominated by the functional groups, in the three molecules are, therefore, almost 
located in the same energy position in the valence spectra (refer to Fig. 6). This again 
indicates that changes in the phenyl ring exhibit minimum effects on the carboxyl 
groups and amino group of the molecules, which has also been illustrated by the core 
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IP spectra presented in the previous section.  
The spectral peaks in the region of 26 eV > IPs > 18 of the three molecules 
align excellently. The orbitals in this region are mostly populated by the C 2s 
electrons, however, with the exception of the peaks at ca. 18 eV – 20 eV of L-tyr and 
L-dopa that also include small p electron contributions from their OH groups on the 
phenyl ring. The region of 18 eV > IPs > 12 eV, which includes orbitals 24a-40a in L-
phe, orbitals 26a-45a in L-tyr and orbitals 28a-48a in L-dopa, show significant 
delocalized molecule-dependent bonding. This chemical bonding region has been 
observed previously in nucleosides49 and other amino acids56. More information 
regarding the orbital densities on the region (see SI.4 –SI.6) indicates that strong 2p 
electron bonding interactions are from the side chain of the molecules. Therefore, this 
mid-valence region (i.e., 18 eV > IPs > 12 eV) that displays complex delocalized 
picture serve as the fingerprint valence region of the molecules. 
Frontier molecular orbitals (MOs) in the outer valence region of the spectra 
provide useful information to understand the properties of the molecules. These outer 
valence MOs contribute two peaks 41a and 42a-44a for L-phe, three peaks 45a, 46a-
47a and 48a for L-tyr and three peaks again, 49a, 50a-51a and 52a for L-dopa, as 
indicated in Fig. 6. While the peak at ca. 11.66 eV is almost unchanged in the 
molecules, the larger L-phe peak splits into two peaks each in L-tyr and L-dopa. Fig. 
7 details the frontier orbitals of the molecules using their molecular energy diagram. 
As seen in this figure, the outermost valence region < 12 eV of the three aromatic 
molecules involves four MOs and the lowest unoccupied molecular orbital (LUMO). 
Although the LUMOs of the molecules exhibit similar bonding nature, the highest 
occupied molecular orbital (HOMO) of L-phe is quite different from the HOMOs of 
L-tyr and L-dopa. The HOMO (44a) of L-phe exhibits electron densities from all over 
the molecule including the phenyl ring and the amino acid moiety. When the hydroxyl 
group(s) replaces the para-H (and meta-H) in L-tyr and/or L-dopa, the HOMO 
electron density of the amino acid moiety is significantly reduced and is transferred to 
the phenyl ring and the hydroxyl groups as shown in Fig. 7. As a result of the 
transferred electron density, the IP of the HOMO reduces in L-tyr and reduced further 
in L-dopa, so that the HOMO-LUMO energy gap reduces from L-phe (4.81 eV) to L-
tyr (4.22 eV) and to L-dopa (4.10 eV). It is noted that the HOMO-1 (47a) and 
HOMO-2 (46a) orbitals of L-tyr are swapped with respect to those in L-phe (43a and 
42a), as shown in Fig. 7. 
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D. Aromaticity  
The frontier MO analyses show noticeable changes in the ‘π’ characters of L-
phe, L-tyr and L-dopa. These changes indicate that the aromatic characters of the 
three molecules may be affected as the result of OH groups in their phenyl rings. 
Further analyses are warranted to understand the changes in their aromaticity 
properties. This study employs NICS-rate index method to evaluate the aromaticity 
features of L-phe, L-tyr and L-dopa.  
Fig. 8 compares the calculated NICS-rate curves of L-phe, L-tyr and L-dopa. 
The minima and the maxima of the NICS-rate curves of the three molecules correlate 
very well, where the minima is reached at a distance of 0.6 Å above the ring and the 
maxima at 1.6 Å above the ring. Indeed the NICS-rate curves display some trends. 
Among the three molecules, L-phe displays a large minimum and a large maximum.In 
the region of < 1.4 Å, the NICS-rate values of L-dopa are the highest, followed by 
those of L-tyr and then by L-phe, i.e., L-dopa > L-tyr > L-phe. In the region of 1.4 Å 
– 3.4 Å, the NICS-rate trend becomes L-dopa ≃ L-tyr < L-phe and finally at any 
distance > 3.4 Å above ring center, the NICS values  of  all   the  three  molecules  are  approximately   the   same   (i.e.,  L-dopa ≃ L-tyr ≃ L-phe). Higher NICS-rate values 
indicate larger aromaticity of the molecule at the given distance. Fig. 8 indicates that 
at small distances (< 1.4 Å), L-dopa is more aromatic, whereas L-phe is more 
aromatic at larger distances. To this regard, dimensionless parameters known as 
NICS-rate ratio (NRR)69 and NRR(σ) were also calculated. NRR is calculated by taking 
the absolute ratio of the maximum and the minimum NICS-rates, as shown by a 
previous study69; whereas, the NRR(σ)46, 76 in this work can be described as,  
 
!""(!) =    !"#$_!"#$(!"#) ∗ !(!"#)!"#$_!"#$(!"#) ∗ !(!"#)   
 
The calculated NICS(0), NRR and NRR(σ) of the molecules are presented in 
Table 3. The NRR(σ) values display an increasing trend from L-phe to L-dopa, i.e., 
3.12 (L-phe) < 4.51 (L-tyr) < 5.99 (L-dopa), which agrees with their NICS(0) and 
NRR values as well (refer to Table 3 for values). All the measures together indicate 
that the aromaticity properties increase with the increasing numbers of OH group 
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substituents. According to the Keto-enol tautomerism of the phenol group77, increase 
in the number of hydroxyl groups in the phenyl ring leads to the extended aromatic 
conjugation. Our results agree very well with this keto-enol tautomerism concept, 
indicating that L-dopa is more aromatic than its amino acid precursors, L-tyr and L-
phe. Increased aromaticity can be yet another feature shown by this study to enhance 
the physico-chemical properties of L-dopa as a drug.  
 
Conclusions 
The effects of OH substitutions on the molecular and electronic properties of the 
aromatic molecules, from L-phe and L-tyr amino acids to L-dopa, a drug for 
neurotransmitter disorders, have been investigated using quantum mechanical 
methods. The geometrical parameters, including the perimeter of the phenyl ring (R6), 
are less affected by the OH substitutions, while other molecular properties, such as 
ionization spectra and aromaticity properties of the molecules display considerable 
changes. The OH substitutions affect the charge redistribution in the molecules, which 
is apparent from the reduction of dipole moments from L-phe to L-dopa.  
 
The intra-molecular interactions of the aromatic molecules are revealed using 
the theoretical photoelectron spectroscopy. It is found that the hydroxyl groups on the 
phenyl ring cause some property changes locally. The phenyl aromatic ring serves as 
a buffer to resist the changes, while the amino acid moiety of the molecules acts 
almost independently from the phenyl ring. The C 1s spectra of L-tyr and L-dopa 
differ from the spectrum of L-phe by the intensity of the middle peak (ca. 291.50 eV), 
which in fact increase at the price of the intensity of the lowest energy peak (ca. 
289.50 eV). The O 1s spectrum of L-dopa features a broader as well as a more 
intensive peak at ca. 536 eV. The Hirshfeld charges also reflect such inner shell 
changes, where the modified carbon sites gain strong positive charges that affect the 
entire phenyl ring in the molecules, most particularly in L-dopa.  
The most significant impact of the OH substitutions in the molecule are 
demonstrated in their valence space, especially in the mid-valence region of 12 eV – 
16 eV and the frontier orbitals. The mid-valence region presents many molecule 
dependent spectral differences, indicating that the significant molecule-specific 
interactions and chemical bonding concentrate in this energy region. The frontier 
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orbitals, on the other hand, undergo much reorganization and energy shifts in 
response to the OH substitutions. The HOMO-LUMO gap decreases with the 
increasing OH groups as, L-phe > L-tyr> L-dopa, which indicate that L-dopa can be 
chemically much reactive than other molecules. Nevertheless, the aromaticity features 
of L-dopa increases substantially against the natural amino acids. Therefere, the OH 
substitituions play a more prominent role in shaping the physico-chemical properties 
of L-dopa, which significantly enhances its’ drug potencies to target neurotransmitter 
disorders. 
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Table 1: Selected molecular properties of L-phe, L-tyr and L-dopa calculated using 
the B3LYP/6-311G** model. Please refer to supplementary information, 
SI.1, for more details on the geometric parameters of the molecules.  
 
Parameters L-phe L-tyr L-dopa 
R6 /Å 8.37 8.38 8.38 
C(1)-C(α)-C(β)-C(γ)/⁰ -73.89 -73.36 -72.36 
N-C(α)-C(β)-C(γ)/⁰ 52.25 52.52 53.25 
µ (Debye) 4.88 3.73 2.86 
<R2> /a.u. 2163.72 2751.02 3075.92 
 
Rotational Constants  
   A /GHZ 1.69 1.55 1.21 
B /GHZ 0.62 0.45 0.42 
C /GHZ 0.55 0.41 0.36 
                      *R6 is the perimeter of the phenyl ring in the aromatic molecules in this work.  
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Table 2: Inner shell vertical IPs of L-phe, L-tyr and L-dopa calculated using the 
LB94/et-pVQZ model along with the available experimental data (eV).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 L-phe  L-tyr 
 L-dopa 
 This work Exp
17 Δ   This work Exp
17 Δ   This work 
C(1) 293.05 294.85 1.80  293.04 294.80 1.76 
 293.13 
C(α) 291.50 291.90 0.40  291.47   
 291.52 
C(β) 290.07    290.06   
 290.12 
C(γ) (ring) 290.03 290.30 0.27  289.93 290.20 0.27 
 290.03 
C(2) (ring) 289.55 290.30 0.75  289.68 290.20 0.52 
 289.75 
C(3) (ring)  289.63 290.30 0.67  289.77 290.20 0.43 
 291.45 
C(4) (ring)  289.65 290.30 0.65  291.40 291.85 0.45 
 291.32 
C(5) (ring)  289.71 290.30 0.59  289.67 290.20 0.53 
 289.68 
C(6) (ring)  289.73 290.30 0.57  289.81 290.20 0.39 
 289.51 
        
  
N 403.72 405.70 1.98  403.70 405.65 1.95 
 403.74 
        
  
O(1) 534.39 538.05 3.66  534.38 538.08 3.70 
 534.48 
O(2) 535.88 539.87 3.99  535.85   
 535.95 
O(3)(ring)      535.87 539.27 3.40  535.69 O(3)(ring)          536.12 
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Table 3: The calculated NICS(0), NRR and NRR(σ) values for L-phe, L-tyr and L-
dopa.  
 
 
NICS values L-phe L-tyr L-dopa 
NICS(0) -8.67 -9.49 -10.45 
NICS-Rate (MAX) 9.94 8.60 8.71 
r(MAX) 1.60 1.60 1.60 
NICS-Rate (MIN) -8.49 -5.08 -3.87 
r(MIN) 0.60 0.60 0.60 
NRR 1.17 1.69 2.25 
NRR(σ) 3.12 4.51 5.99 
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Figure captions 
 
Fig. 1: Schematic representation of the biochemical transformation of aromatic amino 
acids into dopamine. 
 
Fig. 2: Optimized structures of L-phe, L-tyr and L-dopa, along with their 
nomenclatures and Hirshfeld charges calculated using LB94/et-pVQZ model in this 
work. Numberings 1-6 and α, β, and γ denote the carbon atoms.  The colours on the 
atom represent the charge distribution, which can be seen in the online version of the 
manuscript. 
 
Fig. 3: Comparison of the theoretical (LB94-et/pVQZ in this work) and 
experimental17 C 1s (a) and O 1s (b) spectra of L-tyr. The theoretical spectra are 
simulated with an FWHM of 0.47 eV and shifted by 0.45 eV (for C 1s) and 3.52 (for 
O 1s) to match the experiment.  
 
Fig. 4: Comparisons of the C 1s spectra (a) and O 1s spectra (b) of L-phe, L-tyr and 
L-dopa simulated with an FWHM of 0.4 eV and using the LB94/et-pVQZ model.  
 
Fig. 5: Comparison of the valence spectra of L-tyr simulated in this work 
(FWHM=0.5 eV) using the SAOP/et-pVQZ and OVGF/6-311G** against a previous 
experimental spectrum26.  
 
Fig. 6: Valence ionization spectra (FWHM=0.5 eV) of L-phe, L-tyr and L-dopa based 
on the SAOP/et-pVQZ calculations in this work. The MOs of the corresponding peaks 
are marked in the spectra and a few orbital diagrams in the inner valence region are 
also shown. Please refer to supplementary information, SI.3, for the numerical values.  
 
 
Fig. 7: Frontier orbital correlation diagrams of L-phe, L-tyr and L-dopa along with the 
HOMO-LUMO energy gaps of the molecules.  
 
Fig. 8: NICS-rate graph of L-phe, L-tyr and L-dopa calculated as a function of 
distance (Å).  
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